The Phase IVc of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell)
Study on Immunogenicity of Inactivated Enterovirus 71 (EV71) Vaccine (Human Diploid Cell, KMB-17) in Large-scale Healthy Children in China
Sponsor: Chinese Academy of Medical Sciences
This PHASE4 trial investigates Hand, Foot and Mouth Disease (HFMD) and is currently ongoing. Chinese Academy of Medical Sciences leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Dec 2022 — Oct 2023 [monthly]
Unknown Status PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Unknown Status PHASE4
▶ Show 4 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Apr 2019 — Nov 2020 [monthly]
Active Not Recruiting PHASE4
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE4
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
First recorded
Jun 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese Academy of Medical Sciences
- Hubei Provincial Center for Disease Control and Prevention
For direct contact, visit the study record on ClinicalTrials.gov .